Chelmsford, MA 7/25/11—Brooks Automation has acquired Nexus Biosystems, a supplier of automated compound and sample management solutions for life science, for a net cash price of $79 million. For the twelve months ending June 30, Nexus recorded revenues of $36 million. “Together with our other recent acquisition, RTS Life Sciences, and our core technical competencies at Brooks, we plan to build Brooks Life Science Systems into the market and innovation leader in Biobanking and Compound Sample Management,” stated Brooks President and CEO Dr. Steve Schwartz. “With Nexus’s operations on the West Coast and meaningful sales and service locations in Switzerland, Japan and Germany complementing our existing Life Science Systems direct channel presence on the East Coast and in the UK, we will have broad global reach.”